These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 2056131)

  • 1. Recruitment of new osteoblasts and osteoclasts is the earliest critical event in the pathogenesis of human multiple myeloma.
    Bataille R; Chappard D; Marcelli C; Dessauw P; Baldet P; Sany J; Alexandre C
    J Clin Invest; 1991 Jul; 88(1):62-6. PubMed ID: 2056131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
    Kupisiewicz K
    Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on the pathogenesis of osteolysis in multiple myeloma patients.
    Giuliani N; Colla S; Rizzoli V
    Acta Biomed; 2004 Dec; 75(3):143-52. PubMed ID: 15796087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity.
    Martin TJ; Ng KW
    J Cell Biochem; 1994 Nov; 56(3):357-66. PubMed ID: 7876329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of multiple myeloma bone disease.
    Lentzsch S; Ehrlich LA; Roodman GD
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):1035-49, viii. PubMed ID: 17996587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanisms for formation of myeloma bone disease].
    Yata K; Abe M; Matsumoto T
    Clin Calcium; 2008 Apr; 18(4):438-46. PubMed ID: 18379024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanisms of bone lesions in human plasmacytomas.
    Bataille R
    Stem Cells; 1995 Aug; 13 Suppl 2():40-7. PubMed ID: 8520510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
    Kassem M
    APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bone tissue and cancer].
    Rossi JF
    Pathol Biol (Paris); 1990 Jan; 38(1):69-79. PubMed ID: 2407992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rat hindlimb unloading by tail suspension reduces osteoblast differentiation, induces IL-6 secretion, and increases bone resorption in ex vivo cultures.
    Grano M; Mori G; Minielli V; Barou O; Colucci S; Giannelli G; Alexandre C; Zallone AZ; Vico L
    Calcif Tissue Int; 2002 Mar; 70(3):176-85. PubMed ID: 11907715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoclast-osteoblast communication.
    Matsuo K; Irie N
    Arch Biochem Biophys; 2008 May; 473(2):201-9. PubMed ID: 18406338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of bone lesions in multiple myeloma.
    Bataille R; Chappard D; Klein B
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):285-95. PubMed ID: 1582975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells.
    Jimi E; Nakamura I; Duong LT; Ikebe T; Takahashi N; Rodan GA; Suda T
    Exp Cell Res; 1999 Feb; 247(1):84-93. PubMed ID: 10047450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoclast bone resorption is enhanced in the presence of osteoblasts.
    Grano M; Colucci S; Cantatore FP; Teti A; Zambonin Zallone A
    Boll Soc Ital Biol Sper; 1990 Nov; 66(11):1051-7. PubMed ID: 2095815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
    Christiansen P
    APMIS Suppl; 2001; (102):1-52. PubMed ID: 11419022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiopathological basis of bone turnover.
    Masi L; Brandi ML
    Q J Nucl Med; 2001 Mar; 45(1):2-6. PubMed ID: 11456372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloma cell-induced disruption of bone remodelling compartments leads to osteolytic lesions and generation of osteoclast-myeloma hybrid cells.
    Andersen TL; Søe K; Sondergaard TE; Plesner T; Delaisse JM
    Br J Haematol; 2010 Feb; 148(4):551-61. PubMed ID: 19919653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytokines in bone diseases. Cytokines and myeloma bone disease].
    Abe M
    Clin Calcium; 2010 Oct; 20(10):1474-80. PubMed ID: 20890028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development, physiology, and cell activity of bone].
    de Baat P; Heijboer MP; de Baat C
    Ned Tijdschr Tandheelkd; 2005 Jul; 112(7):258-63. PubMed ID: 16047964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biology of the basic multicellular unit and the pathophysiology of osteoporosis.
    Jilka RL
    Med Pediatr Oncol; 2003 Sep; 41(3):182-5. PubMed ID: 12868116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.